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Transcription factor NF-E2-related factor 2 (Nrf2) is important for cell protection against chemical-induced 
oxidative stress. Previously, we have reported that in PC12 cells, Nrf2 can be triggered by deltamethrin 
(DM), a commonly used pyrethroid insecticide. Molecular mechanisms behind Nrf2 activation by DM are 
still unclear. Here we studied the effects of cell glutathione (GSH) depletion on Nrf2 activation by DM. We 
found that DM enhanced Nrf2 expression at the mRNA and protein levels and increased nuclear Nrf2 levels. 
Activation of Nrf2 was associated with activation of its downstream targets, such as heme oxygenase-1 
(HO-1) and glutamate cysteine ligase catalytic subunit (GCLC). In contrast, DL-buthionine-[S,R]-
sulfoximine (BSO), a known GSH-depleting agent, did not increase Nrf2 protein expression or cause its 
nuclear accumulation. However, pre-treatment with BSO triggered mRNA expression of HO-1 and GCLC. 
Furthermore, BSO pre-treatment suppressed DM-induced Nrf2 upregulation and activation and lowered 
mRNA expression of HO-1 and GCLC upon DM treatment. These data demonstrate that GSH depletion is 
not necessary for the activation of Nrf2/ARE by DM in PC12 cells, and that GCLC and HO-1 expression 
can increase through other signalling pathways.
KEY WORDS: BSO, DL-buthionine-[S,R]-sulfoximine, glutamate cysteine ligase catalytic subunit, GCLC, 
heme oxygenase, HO-1, pyrethroid insecticide
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Pyrethroids are widely used agricultural pesticides 
because of their effectiveness as nerve poisons and 
their low environmental impact (1). The most effective 
of the group is deltamethrin [(S)a-cyano-3-
phenoxybenzyl-(1R)-cis-3-(2.2-dibromovinyl)-2,2-
dimethylcyclopropanecarboxylate, DM], which causes 
neurological disorders (choreoathetosis with salivation, 
also known as CS syndrome) (1, 2).
Transcription factor NF-E2-related factor 2 (Nrf2), 
a part of the Cap’n’Collar family of basic leucine 
zipper (bZIP) proteins, plays a key role in the activation 
of multiple genes encoding antioxidants and phase II 
drug-metabolising enzymes through antioxidant 
response elements (AREs) (3, 4). AREs are located in 
the 5’-ﬂ anking region of various genes engaged in the 
cellular protection against oxidative stress, such as the 
glutamate cysteine ligase modiﬁ er subunit (GCLM) 
(5-7), heme oxygenase 1 (HO-1) (8-11), and the 
glutamate cysteine ligase catalytic subunit (GCLC).
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Glutamate cysteine ligase (GCL) is the first 
enzyme in the pathway of glutathione (GSH) 
synthesis. GCL is a heterodimeric enzyme containing 
a catalytic subunit (GCLC), which is capable of 
catalysis alone, and a modiﬁ er subunit (GCLM), which 
increases the catalytic efﬁ ciency of GCLC and reduces 
feedback inhibition by GSH. Synchronised induction 
of these enzymes should protect the cell against the 
adverse effects of reactive oxygen species (ROS).
We have previously reported that DM enhances the 
release of free radicals and nuclear translocation of the 
stress response transcription factor Nrf2 in rat brain 
and PC12 cells in vitro (12, 13). Several mechanisms, 
including oxidation of redox-sensitive cysteines in 
Keap1 (14), ubiquitination (15, 16), phosphorylation 
(17, 18), and nuclear shuttling (19, 20), have been 
proposed to regulate Nrf2 activity. In spite of their 
differences, all of these mechanisms seem to involve 
Keap1 protein-mediated recognition and transduction 
of signals for Nrf2 activation. A study by Goldring et 
al. (21) has shown that diethylmaleate (DEM), a GSH-
depleting agent, can release Nrf2 in vivo, permitting 
its nuclear translocation and coordinated upregulation 
of ARE-driven defence genes. These ﬁ ndings imply 
that a relationship between nuclear translocation of 
Nrf2 and GSH level depends on whether exposure 
involves a substance with inherent protein reactivity.
The rationale for testing whether GSH depletion 
affects Nrf2 induction by DM is to see if DM triggers 
Nrf2 activation through GSH depletion or the process 
involves other chemical stressors. With this in mind, 
we studied the effects of GSH depletion on Nrf2 
activated by DM in differentiated PC12 cells, a rat 
adrenal pheochromocytoma cell line with the 
phenotypic properties of sympathetic neurons, which 




Deltamethrin (DM, 98.5 %) was purchased from 
Roussel-Uclaf Corp. (Romainville Cedex, France). 
The TRIzol® reagent was purchased from Life 
Technologies (Foster, CA, USA). rTaq (recombinant 
Taq) DNA polymerases, ReverTra Ace (MMLV 
Reverse Transcriptase RNaseH-), and an RNase 
inhibitor were obtained from Toyobo Co., Ltd. (Osaka, 
Japan). All primers were synthesized by BIOASIA 
biologic technology Co., Ltd. (Shanghai, China). 
Random Primers were purchased from Promega 
(Shanghai, China) and dNTPs were procured from 
Shengong Co., Ltd. (Shanghai, China).
Anti-Nrf2 antibodies (C-20: sc-722) (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA) were a kind 
gift from Professor Ma Qiang (NIOSH, USA). Anti-
HO-1 antibodies were obtained from Santa Cruz 
Biotechnology Inc.. Dulbecco’s Modified Eagle 
Medium (DMEM) was procured from HyClone 
(Logan, UT, USA). Fluorescein isothiocyanate (FITC)-
conjugated goat anti-rabbit IgG antibodies were 
obtained from Proteintech Group Inc. (Chicago, IL, 
USA). DL-buthionine-[S,R]-sulfoximine (BSO), 
dimethyl sulfoxide (DMSO), RNase A, and propidium 
iodide (PI) were obtained from Sigma Chemical Co. 
(St. Louis, MO, USA). NC membranes were purchased 
from Millipore (Bedford, MA, USA). The enhanced 
chemiluminescence reagent was obtained from 
HyClone-Pierce company. HEPES, EDTA, MgCl2, 
KCl, DTT, sodium orthovanadate, NaF, PMSF, 
benzamidine, leupeptin, aprotinin, and NP-40 were 
obtained from Shanghai Chemical Reagent Company 
of the Chinese Medical Group (Shanghai, China).
Culture and treatment of PC12 cells
Differentiated PC12 cells were obtained from the 
Institute of Cell Biology of the Chinese Academy of 
Sciences (Shanghai, China). They were cultivated in 
DMEM supplemented with 10 % heat-inactivated 
foetal bovine serum at 37 °C in a humidified 
atmosphere consisting of 95 % air and 5 % CO2. The 
medium was replaced every other day, and cells plated 
at a density adjusted to the experimental needs. After 
an incubation period of 24 h, cells were transferred 
to a serum-free culture medium and treated.
Based on previous results (23, 24), in this 
experiment we used BSO in the concentration of 
500 μmol L-1 reconstituted with DMSO in the ﬁ nal 
concentration not over 0.1 % so as not to inﬂ uence the 
evaluated parameters (data not shown).
PC12 cells were incubated with 500 μmol L-1 BSO 
for 16 h immediately after they were transferred to a 
serum-free culture medium. Negative control cultures 
were not exposed to BSO, and exposure to BSO did 
not affect cell viability (data not shown).
Following BSO exposure the cells were treated with 
10 μmol L-1 DM for 1 h.
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Semiquantitative reverse transcription polymerase 
chain reaction (RT-PCR) analysis
Reverse transcription PCR was done as reported in 
our earlier paper (25). Total RNA from PC12 cells was 
extracted using the TRIzol® Reagent, in line with the 
manufacturer’s instructions. The reaction volumes were 
20 μL. Incubations at 42 °C lasted 45 min, at 70 °C 
15 min, and ﬁ nally at 37 °C 20 min. PCR was carried 
out sequentially. Primer sequences for cDNA 
ampliﬁ cation are listed in Table 1.
Pre-denaturation was set to 10 min at 94 °C; 
denaturation (35 cycles) to 60 s at 94 °C, annealing to 
30 s at 55 °C, extension to 60 s at 72 °C, while the 
final single extension at 72 °C lasted 5 min. For 
internal control we used a 188-bp DNA fragment of 
the rat glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) gene and ampliﬁ ed it in the same PCR 
system as the tested gene.
The obtained PCR products were then resolved 
by agarose gel electrophoresis. After staining with 
ethidium bromide, DNA in gel was visualised under 
ultraviolet light. The experimental values were 
normalised to the corresponding GAPDH values.
Immunocytochemical detection of HO-1
Protein expression of HO-1 was detected by 
immunocytochemistry. PC12 cells were cultivated on 
poly-L-lysine-coated coverslips as described by 
Deptala et al. (26) with slight modiﬁ cations. After the 
treatment, the cells were rinsed with PBS twice and 
ﬁ xed in 95 % ethanol at -20 °C for 15 min. After a 
second wash in PBS, the ﬁ xed cells were permeabilised 
in 0.2 % Triton X-100 in PBS for 15 min, rinsed with 
pure PBS and blocked with normal goat serum at room 
temperature for 30 min. The cells were ﬁ rst treated 
with an anti-HO-1 antibody (in the dilution of 1:50) 
at 4 °C for 18 h and then incubated with FITC-labelled 
goat anti-rabbit IgG (H+L) at 37 °C for 30 min.
After the cells were rinsed with PBS, microscope 
slides were prepared. We used a 50 % glycerin buffer 
solution as a mounting medium. Slides were examined 
on a laser scanning confocal microscope equipped 
with a UPLAPO 100x oil immersion objective lens 
(Fluoview FV500, Olympus, Tokyo, Japan). The 
imaging settings were optimised to ensure signal 
detection and consistency of images. Imaging data were 
processed using Fluoview version 4.3.53 and analysed 
using image-Pro Plus version 5 (Media Cyberbetics 
Inc., Bethesda, MD, USA) and Adobe Photoshop 8.0 
(Adobe Inc., San Jose, CA, USA). The images were 
analysed by an investigator blind to this treatment 
protocol. HO-1 expression was checked by measuring 
whole-cell FITC signal intensity.
Preparation of cytosolic and nuclear extracts
Cytosolic and nuclear extracts were isolated 
according to Schreiber et al. (27) with some 
modiﬁ cations. After rinsing with cold PBS, cells were 
resuspended in cold lysis buffer A (20 mmol L-1 
HEPES pH 8.0, 1 mmol L-1 EDTA, 1.5 mmol L-1 
MgCl2, 10 mmol L
-1 KCl, 1 mmol L-1 DTT, 1 mmol L-
1 sodium orthovanadate, 1 mmol L-1 NaF, 1 mmol L-1 
PMSF, 0.5 mg mL-1 benzamidine, 0.1 mg mL-1 
leupeptin, and 1.2 mg mL-1 aprotinin).
They were incubated on ice for 15 min, after which 
7.5 μL of 10 % NP-40 detergent was added. Afterwards 
the cells were intensively stirred in a vortex mixer for 
10 s. The homogenate was centrifuged at 16,000 g for 
50 s, and the supernatant was used as the cytosolic 
extract. The nuclear pellet was resuspended in cold 
extraction buffer B (20 mmol L-1 HEPES pH 8.0, 
Table 1 Primer sequence used in RT-PCR analysis 





γ- GCLC 5’-CATCTACCACGCAGTCAA-3’ 351
3’-GCTATTGAAGTAAAGGGTC-5’




bp – base pairs
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1 mmol L-1 EDTA, 1.5 mmol L-1 MgCl2, 10 mmol L
-1 
KCl, 1 mmol L-1 DTT, 1 mmol L-1 sodium orthovanadate, 
1 mmol L-1 NaF, 1 mmol L-1 PMSF, 0.5 mg mL-1 
benzamidine, 0.1 mg mL-1 leupeptin, 1.2 mg mL-1 
aprotinin, and 20 % glycerol). All protein fractions were 
stored at -70 °C until used, and protein concentrations 
were determined with the Bradford method, using 
bovine serum albumin as the standard.
Western blotting analysis
Protein samples were resolved on 10 % SDS-
polyacrylamide gels and were transferred to 
nitrocellulose membranes. Membranes were blocked 
in Tris-buffered saline (TBS) with 0.1% Tween-20, and 
5 % nonfat dry milk for 1 h. After that they were 
incubated overnight with primary antibodies diluted in 
the identical buffer. Nrf2 was used in the dilution of 
1:500; and GAPDH in the dilution of 1:8,000. After the 
washing with 0.1 % Tween-20 in TBS, the membranes 
were incubated with peroxidase-conjugated secondary 
antibodies for 1 h and then rinsed and developed using 
the ECL chemiluminescent detection system. Blots 
were then visualised with X-ray ﬁ lms. The results were 
analysed using the Bandscan 4.3 software. Densitometry 
was normalised against the signal obtained from co-
incubation with anti-GAPDH.
Measurement of the reduced GSH content
The reduced GSH content was measured using 
reversed-phase high performance liquid chromatography 
with o-phthalaldehyde precolumn derivatisation as 
described elsewhere (13, 28).
Statistical analysis
Data bars correspond to mean values ± SD of 
minimum three independent experiments. The results 
were evaluated using SPSS for Windows (version 18.0, 
Chicago, IL, USA). Differences between the groups 
were assessed using one-way analysis of variance 
(ANOVA). If the F values were signiﬁ cant, LSD post 
hoc tests were employed for multiple comparisons 
between the groups. The value of P≤0.05 was deemed 
statistically signiﬁ cant.
RESULTS
Effects of DM on the Nrf2/ARE pathway
Using cytosolic and nuclear fractions of PC12 cells 
to establish the relative distribution of Nrf2 we found 
that Nrf2 migrated with a molecular weight of around 
100 kDa. Such an atypical migration was previously 
observed in human neuroblastoma cells (29).
As proposed by Shukla et al. (30), samples from the 
nuclear fraction resolved on parallel gels were stained 
with Coomassie brilliant blue for protein visualisation, 
and analysed with Western blot to detect the target 
protein. Save for the evidently increased signal intensity 
in the 100 kDa molecular weight fraction, the protein 
distribution pattern in PC12 cells treated with DM or 
BSO resembled that of untreated cells. This suggests 
that the nuclear protein loaded in the gel lanes was of 
the same amount (data not shown), and that the 100 
kDa band corresponded to the speciﬁ c recognition of 
Nrf2 antibodies. Protein expression of Nrf2 increased 
after DM treatment both in the nuclear and the cytosolic 
fractions compared to control PC12 cells (Figure 1). 
Figure 1  Effect of BSO pre-treatment on DM-induced 
expression of the Nrf2 protein in PC12 cells. Cells 
were incubated with or without 500 μmol L-1 BSO 
for 16 h, followed by exposure to 10 μmol L-1 DM for 
1 h. Protein expression was examined using the 
Western blot analysis. Equal amounts of protein 
(45 μg) extract were loaded onto each lane of 8.0 % 
SDS-PAGE gels, and the blot was probed with the 
polyclonal anti-Nrf2 antibody (1:400) overnight and 
visualized by chemiluminescence. (A) representative 
Western blot images of Nrf2. Western blot for 
GAPDH, a cytoplasmic marker, was used as internal 
control and indicated that the nuclear fraction was 
not contaminated; (B) immunoﬂ uorescent intensity 
evaluated by quantifying the ratio between the 
relative level of target protein expression in the 
experimental group and relative level of target 
protein expression in the control group, normalised 
in respect to control. Values are mean ± standard 
deviation of three determinations.
* P<0.05 compared to control; # P<0.05 compared 
to DM;  P<0.05 compared to BSO
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This implies that DM may induce Nrf2 expression and 
facilitate Nrf2 activation. To establish the effects of 
DM on Nrf2 gene transcription, we analysed Nrf2 
mRNA expression using RT-PCR. The data showed that 
the mRNA level of Nrf2 was also elevated upon DM 
treatment (Figure 2). The enhanced expression and 
nuclear translocation of Nrf2 indicates that the 
expression of antioxidant and phase II detoxiﬁ cation 
genes might also be enhanced through Nrf2-mediated 
transcriptional activation of ARE-containing genes. To 
verify this assumption, we assessed the mRNA levels 
of HO-1 and GCLC, two acknowledged Nrf2-targeted 
antioxidant genes, and observed that the mRNA level 
of HO-1 in PC12 cells indeed increased 1.7 fold by DM 
treatment (Figure 2).
This increase in HO-1 mRNA expression was 
linked with an even greater, 6.4-fold increase in its 
protein expression (Figure 3) in respect to untreated 
cells. In PC12 cells treated with DM, the GCLC mRNA 
level also increased (Figure 2) compared to control. In 
summary, our data show that Nrf2 activation by DM 
induced the expression of several Nrf2-regulated genes 
in PC12 cells.
Figure 2  Effect of BSO on DM-induced expression of Nrf2, 
HO-1 and mRNA GCLC/M. PC12 cells were 
incubated with or without 500 μmol L-1 BSO for 16 h, 
followed by exposure to 10 μmol L-1 DM for 1 h. Total 
RNA in cells was isolated and subjected to RT-PCR. 
mRNA expression was examined by semi-quantitative 
RT-PCR. (A) agarose gel electropherogram for RT-
PCR products from these genes and (B) mRNA 
expression evaluated by quantifying the ratio 
between band densitometry of the target gene and 
GAPDH, normalised in respect to control. Values 
are mean ± s tandard deviat ion of  three 
determinations.
* P<0.05 compared to control; # P<0.05 compared 
to DM;  P<0.05 compared to BSO
Figure 3  Ef f ec t  o f  BSO on  DM- increased  HO-1 
immunoﬂ uorescent intensity. PC12 cells were grown 
on cover slips and incubated with or without 
500 μmol L-1 BSO for 16 h, followed by exposure to 
10 μmol L-1 DM for 1 h. The HO-1 protein level was 
determined as described in Materials and Methods. 
Cover slips were mounted on glass slides with 
ﬂ uorescent mounting medium and visualised using 
a LSCM with a 100x objective. (A) ﬂ uorescence 
images of a typical experiment and (B) ratio between 
HO-1 in the experimental group and control, 
normalised in respect to control. Values are mean ± 
standard deviation of three determinations.
* P<0.05 compared to control;  P<0.05 compared 
to BSO.
Effects of BSO pre-treatment on the nuclear 
translocation of Nrf2 induced by DM
GSH depletion triggers oxidative stress and is 
considered a major activator of the Nrf2-ARE pathway. 
To further clarify the requirement of GSH depletion 
in Nrf2 activation, we pre-treated PC12 cells with 
BSO, a known GSH-depleting agent, and then with 
DM to assess changes in the expression and subcellular 
distribution of Nrf2. Compared to vehicle-treated 
controls, cells treated with BSO alone showed no 
change in Nrf2 expression or its distribution (Figure 
1). However, compared to the DM-treated cells, cells 
pre-treated with BSO had a lower Nrf2 protein level 
in both the nucleus and the cytosol (Figure1), indicating 
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that BSO inhibited DM-induced Nrf2 activation and 
translocation.
Effects of BSO pre-treatment on DM-increased 
mRNA expression of GCS, HO-1, and Nrf2 
We then measured the effects of BSO pre-treatment 
on the expression of Nrf2 and Nrf2-regulated genes 
HO-1, GCLC, and GCLM to explain the molecular 
mechanism behind Nrf2 activation by DM. The mRNA 
levels of HO-1, GCLC, and GCLM were measured in 
PC12 cells treated with DM or BSO. Cells treated with 
BSO alone showed increased GCLC and HO-1 mRNA 
expression, but decreased GCLM mRNA expression 
compared to vehicle-treated controls. However, Nrf2 
mRNA expression was unchanged, indicating that BSO 
promotes gene expression in an Nrf2-independent 
manner. The alternative explanation is that GSH 
depletion can directly enhance mRNA expression of 
GCLC and HO-1. When compared to the DM-treated 
cells, cells pre-treated with BSO before DM treatment 
had lower GCS-h and HO-1 mRNA expression and a 
modest increase in the Nrf2 mRNA level (Figure 2), 
suggesting that BSO pre-treatment could suppress 
DM-induced upregulation of GCLC and HO-1 
mRNA.
Effects of BSO pre-treatment on DM-increased 
protein expression of HO-1
Both BSO alone and DM alone increased HO-1 
protein expression (Figure 3B). In cells pre-treated with 
BSO for 16 h followed by DM exposure, HO-1 mRNA 
expression was slightly lower than in cells treated with 
DM or BSO alone. Surprisingly, BSO did not suppress 
DM-induced upregulation of the HO-1 protein. On the 
contrary, a slight increase was observed (Figure 3B), 
indicating a synergistic effect of BSO and DM.
Effect of BSO pre-treatment on the GSH content in 
PC12 cells treated with DM
DM alone had no effect on the GSH content, 
whereas BSO alone and BSO+DM decreased it 
significantly by 44.0 % and 68.1 %, respectively 
(Figure 4). However, the difference in GSH levels 
between BSO and BSO+DM treatment was not 
signiﬁ cant (Figure 4).
DISCUSSION
Several studies have shown that oxidants and 
xenobiotics might activate inactive Nrf2 by facilitating 
its translocation from the cytoplasmic compartment 
towards the nucleus (31, 32). To establish whether DM 
controls Nrf2 activity in such a way, we determined 
Nrf2 levels in subcellular fractions after DM treatment. 
The original hypothesis has been that Nrf2 level in the 
cytosolic fraction would decrease, with a simultaneous 
increase in the nuclear fraction. However, DM 
treatment increased Nrf2 protein levels in both the 
cytosolic and the nuclear fractions at the same time 
(Figure 1). This DM-induced Nrf2 upregulation was 
also observed at the mRNA level by RT-PCR, indicating 
that increased Nrf2 protein level in DM-treated PC12 
cells was, at least to some extent, caused by enhanced 
Nrf2 gene transcription. Our ﬁ ndings undoubtedly 
conﬁ rm the association between DM exposure and 
elevated cellular and nuclear accumulation of Nrf2, 
which consequently promotes the expression of Nrf2-
regulated oxidative stress response genes (Figure 1).
Generally, in in vitro toxicology studies, chemical 
treatment in culture media should be conducted under 
serum-free conditions. This is why we transferred the 
PC12 cells after initial 24-h incubation to a serum-free 
culture medium for treatment. How serum deprivation 
affected Nrf2 protein expression or nuclear 
accumulation was unclear. Nevertheless, the addition 
of DM or BSO into serum-free culture medium 
signiﬁ cantly affected Nrf2 protein expression and 
nuclear accumulation compared to control.
DM treatment had no effect on GSH content, 
whereas BSO alone and BSO+DM had a similar 
Figure 4 Effect of BSO pre-treatment on GSH content in PC12 
cells treated with DM. PC12 cells were pre-incubated 
with 500 μmol L-1 BSO for 16 h, followed by exposure 
to 10 μmol L-1 DM or vehicle for 1 h. Reduced 
glutathione (GSH) content was determined by 
reversed-phase HPLC with o-phthalaldehyde pre-
column derivatisation.
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signiﬁ cantly decreasing effect on (Figure 4). BSO was 
used to see whether nuclear Nrf2 level increased by 
DM in PC12 cells were mediated by GSH. In contrast 
to DM, BSO did not signiﬁ cantly increase nuclear Nrf2, 
which suggests that GSH depletion alone could not 
cause Nrf2 upregulation or activation. It is known that 
BSO irreversibly binds GCLC and is not likely to 
produce ROS or chemically reactive metabolites that 
can modify cellular macromolecules (33). In contrast, 
DM requires metabolism to induce extensive covalent 
modiﬁ cation of cellular proteins.
Goldring et al. (21) have proposed that Nrf2 may 
be activated in mice liver by its dissociation from the 
cytoplasmic inhibitor Keap1 either through a redox-
sensitive mechanism related to GSH depletion or 
through Michael addition (21).
However, the results we obtained with BSO suggest 
that lowering the GSH level did not induce nuclear 
translocation of Nrf2 (Figure 1 and Figure 4). Instead, 
BSO pre-treatment inhibited Nrf2 activation and 
nuclear translocation provoked by DM (Figure1), 
suggesting a mechanism of Nrf2 activation independent 
of GSH depletion. Therefore, a more direct interaction 
may be involved, probably related to chemical 
modiﬁ cation of Nrf2 or Keap1 potentiated by the earlier 
loss of GSH.
Nguyen et al. (32) identiﬁ ed nine distinct classes 
of Nrf2 inducers that share several characteristics: a) 
all are chemically reactive; b) most are electrophiles; 
c) many are substrates for GSH S-transferases; and 
d) all can covalently modify sulphydryl groups by 
alkylation, oxidation, or reduction. So far, various 
mechanisms have been suggested to explain Nrf2 
activation, including oxidation of redox-sensitive 
cysteine residues in Keap1, phosphorylation of Nrf2, 
and covalent adduct formation with protein stabilisation 
(31).
The ﬁ ndings of Goldring et al. (21) imply that 
changes in the Nrf2 system may not depend on toxicity 
related to changes in the GSH level, but could be 
associated with the formation of chemically reactive 
or electrophilic species. Indeed, Zhang et al. (34) have 
found that 4-hydroxynoneneal, a lipid peroxidation 
product, induces Nrf2 at sub-toxic concentrations. This 
ﬁ nding supports the idea that chemically reactive 
electrophilic species can activate Nrf2, and that Keap1 
degradation is probably not required for Nrf2 
translocation. 
In our study, Nrf2 mRNA expression was not 
suppressed by BSO+DM. However, BSO pre-treatment 
did inhibit its DM-mediated increase in protein level 
in the cytoplasm and the nucleus. This inhibitory effect 
of BSO on Nrf2 activation and translocation may be 
mediated by the effects of BSO on ROS accumulation. 
Earlier ﬁ ndings in DM-exposed PC12 cells showed 
that ROS mediated nuclear accumulation of Nrf2 (25). 
Moreover, increased nuclear accumulation of Nrf2 
after DM exposure was associated with the production 
of free radicals in rat brain (12). Pre-treatment with 
BSO for 16 h significantly reduced DM-induced 
increase in DCF fluorescence intensity (by about 
40 %), indicating that BSO could attenuate ROS 
production induced by DM (35). Taken together, these 
data suggest that Nrf2 activation may rely on 
chemically reactive metabolites generated through a 
DM-mediated protein modiﬁ cation. Therefore, BSO 
pre-treatment may inhibit DM-induced Nrf2 activation 
and translocation by decreasing ROS levels in PC12 
cells.
Induction of HO-1 by Nrf2 through ARE has 
recently been established using Nrf2 dominant-
negative mutants (Nrf2M) (36). Recent experiments 
(6, 37-41) have also shown that Nrf2 takes place in 
both basal and induced expression of multiple ARE-
containing genes that encode detoxiﬁ cation enzymes 
and human GCLC and GCLM.
It has already been established that BSO, an 
inhibitor of gamma-glutamylcysteine synthetase and 
the rate-limiting enzyme in the biosynthesis of GSH, 
increases HO-1 enzyme activity, HO-1 protein 
expression, and HO-1 mRNA expression in rat brain 
and liver cell lines (42-46). However, our results have 
demonstrated that BSO can induce HO-1 and GCLC 
mRNA expression without affecting Nrf2 translocation 
(Figure 1 and Figure 2), precluding therefore the 
involvement of Nrf2-ARE signalling. HO-1 and GCLC 
expression is, in fact, altered by redox-sensitive 
transcription factors that recognise particular binding 
sites within the promoter and distal enhancer regions 
of these genes (3, 47). These transcription factors 
include Fos/Jun activator protein-1 (AP-1), nuclear 
factor-κB (NF-κB), and the newly recognised Nrf2 
proteins (48, 49). Additionally, HO-1 is quickly 
upregulated by oxidative and nitrosative stress and by 
GSH depletion as well (50-52).
In a study with rat lung epithelial L2 cells exposed 
to oxidative stress or GSH depletion, Tian et al. (53) 
have found evidence for enhanced transcription of the 
regulatory subunit of gamma-glutamylcysteine 
synthetase. GCS mRNA expression also increased in 
rat myocardium, although GCS activity is suppressed 
by BSO (54). Urata et al. (55) have also found that 
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BSO can trigger the transcription factor NF-κB. We 
speculate that HO-1 and GCLC upregulation induced 
by BSO might be mediated by Fos/Jun (AP-1) or NF-
κB in PC12 cells. Thus, GCS and HO-1 induction by 
DM alone or by BSO alone may follow different 
signalling pathways. We also found that BSO pre-
treatment increased HO-1 protein upregulation by DM. 
It is possible that this upregulation may involve 
transcription factors other than Nrf2, such as Fos/Jun 
(AP-1) or NF-κB.
GCS subunits seem ro follow different regulation 
pathways. However, Gipp et al. (56) did not ﬁ nd a 
correlation between the steady-state mRNA levels of 
the two GCS subunits. In our study, the expression of 
GCS subunits was signiﬁ cantly affected by DM, and 
GCLC mRNA levels increased (Figure 2), whereas 
GCLM mRNA levels did not change (Figure 2). This 
discrepancy might be due to a different response to 
DM exposure. An additional factor that complicates 
characterising DM-related decrease in ARE-dependent 
gene transcription is the effect of other interacting 
partners on Nrf2, because Nrf2 makes heterodimers 
with other bZip proteins, for instance the Jun/Fos 
family, Fra, small Maf, and ATF4 proteins (3, 40, 57, 
58).
Partnering factors could inﬂ uence Nrf2-dependent 
gene expression, either through stimulating or reducing 
it. It has not yet been established whether relative 
proportions of these partner proteins change in DM-
treated PC12 cells. It will be interesting to investigate 
possible DM-associated changes in these factors, above 
all the Jun/Fos family members and their effects on 
ARE-mediated gene transcription.
In conclusion, this study has demonstrated that DM 
can induce Nrf2 nuclear accumulation. Depletion of 
GSH does not seem necessary for Nrf2 activation. Our 
results suggest that Nrf2 activation may rely on 
chemically reactive metabolites derived from 
covalently modiﬁ ed intracellular molecules that are 
altered by the highly reactive DM. These data also 
suggest that GCS and HO-1 induction by DM and BSO 
follows different signalling pathways.
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Sažetak
ULOGA DEPLECIJE GLUTATIONA U AKTIVACIJI NRF2/ARE DELTAMETRINOM U ŠTAKORSKIM 
PC12-STANICAMA FEOKROMOCITOMA
Transkripcijski čimbenik 2 povezan s NF-E2 (Nrf2) važan je za zaštitu stanice od oksidacijskog stresa 
uzrokovanog kemijskim spojevima. U prijašnjem smo istraživanju utvrdili da često rabljeni piretroidni 
insekticid deltametrin aktivira Nrf2 u štakorskim PC12-stanicama feokromocitoma. Još međutim nisu jasni 
molekularni mehanizmi te aktivacije. U ovome smo istraživanju željeli utvrditi ulogu deplecije staničnoga 
glutationa (GSH) u aktivaciji Nrf2 od strane DM-a. DM je pojačao ekspresiju Nrf2 u mRNA te povisio 
razinu proteina i razinu Nrf2 u jezgri. Aktivacija Nrf2 bila je povezana s nizvodnom aktivacijom hem-
oksigenaze 1 (HO-1) i katalitičke podjedinice glutamat cistein ligaze (GCLC). DL-butionin-[S,R]-
sulfoksimin (BSO), za koji se zna da dovodi do deplecije GSH, nije međutim povećao ekspresiju Nrf2-
proteina niti doveo do njegova nakupljanja u staničnoj jezgri. Prethodna primjena BSO aktivirala je međutim 
ekspresiju HO-1 i GCLC u mRNA. Usto je suprimirala djelovanje DM-a na aktivaciju i regulaciju Nrf2 
te smanjila ekspresiju HO-1 i GCLC u mRNA nakon primjene DM-a. Ova saznanja govore da deplecija 
GSH nije nuždan mehanizam za aktivaciju Nrf2/ARE od strane DM-a u PC12-stanica te da do povećane 
ekspresije GCLC i HO-1 može doći drugim signalnim putovima.
KLJUČNE RIJEČI: BSO, DL-butionin-[S,R]-sulfoksimin, katalitička podjedinica glutamat cistein ligaze, 
GCLC, hem-oksigenaza, HO-1, piretroidni insekticid
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